黄金城游戏

Special qPCR compendium issue of DECODED now freely available

CORALVILLE, IA –06 August 2014 – Integrated DNA Technologies (IDT), the world leader in oligonucleotide synthesis, is sharing its wealth of qPCR expertise and knowledge in a special qPCR compendium edition of the DECODED newsletter, available free of charge online.

In this issue, number 4.2, researchers can read an interview with internationally recognized expert on quantitative PCR, Dr Jo Vandesompele. Discussing the common issues researchers face when using qPCR, and the future direction of the technology, Dr Vandesompele notes a trend towards digital PCR (dPCR). For those who want to discover dPCR in more depth there is a special article dedicated to the topic – ‘Digital PCR (dPCR) – what is it and why use it?’, which gives a detailed introduction into how the technology works and its applications.

As well as an abundance of practical knowledge and ‘how to’ guides on e.g. primer and probe design, handling oligonucleotides and multiplexing, there are also interesting application articles such as the optimization of multiplex qPCR for detecting infectious diseases and biothreat agents. In this article scientists at Tetracore, a biodefense company based in Rockville, MD, USA, explain how IDT’s ZEN™ Double-Quenched probes have been invaluable to their work.

This exclusive edition of DECODED offers something for all researchers interested in qPCR, from experienced users to those new to the technology. With the release of the compendium, IDT has also re-vamped the DECODED pages improving the navigation and content format. New articles and practical knowledge will now be continuously added, providing a consistent resource to aid scientists in their research.

For more information please visit www.idtdna.com. Follow us on twitter @idtdna for real-time updates and insights.

About IDT

Integrated DNA Technologies (IDT) is the largest supplier of custom nucleic acids in the world, serving academic, government, and commercial researchers in biotechnology, clinical diagnostics, and pharmaceutical development. IDT's primary business is the manufacture of custom, synthetic DNA and RNA oligonucleotides. Today, IDT synthesizes and ships an average of 36,000 custom oligos per day to more than 86,000 customers worldwide. IDT manufacturing locations include facilities in Coralville, Iowa; San Diego, Calif.; Leuven, Belgium; and Singapore. For more information visit www.idtdna.com.

Integrated DNA Technologies

800-328-2661 (US & Canada)

+1 319-626-8400 (outside US)

[email protected]

www.idtdna.com